The goal of this study is to conduct a prospective, longitudinal natural history study of children and adults with Angelman Syndrome using investigator-observed and parent-reported outcome measures to obtain data that will be useful for future clinical trials.
The overall goal is to increase our understanding of the long-term natural history of Angelman syndrome and obtain Angelman-specific norms for outcome measures that can be used in clinical trials, ultimately improving the care of individuals with Angelman syndrome.
Molecular diagnosis of Angelman syndrome
Presence of another condition, unrelated to Angelman syndrome, that affects neurodevelopment
August 4, 2021
For more information on this trial, visit clinicaltrials.gov.
For more information and to contact the study team: